As a leading clinical research center in MENA region, M.A.R.C for Medical Services & Scientific Research, receives GCC Health Council Accreditation for its bioequivalence unit. Such accreditation represents a testament to our continuous innovation, commitment to quality healthcare, and advancing medical research in the region.

M.A.R.C receives GCC Health Council Accreditation for its bioequivalence unit.


medium_1715412448781.jpeg

small_1715412448781.jpeg

thumbnail_1715412448781.jpeg

1715412448781.jpeg

Bioequivalence Unit receives GCC Accreditation.

MARC hosted the inaugural workshop of the National Pharmacomicrobiomics Alliance, a project funded by the Egyptian Academy of Scientific Research and Technology (ASRT) under the JESOR program. Led by MARC, the alliance brings together scientists from the Faculty of Pharmacy at Cairo University, Future University in Egypt, and Children’s Cancer Hospital Egypt 57357, with the aim of advancing pharmacomicrobiomics in Egypt, training young scientists, and promoting technology exchange with US-Egyptian experts.

The workshop welcomed prominent leaders in higher education and scientific research, along with senior and junior microbiome specialists from across Egypt. The project’s US-Egyptian partner, Dr. Mohamed Aboudonia of Princeton University and a pioneer in microbiome research, delivered the keynote presentation, highlighting cutting-edge technologies developed in his laboratory and outlining opportunities and challenges for the Egyptian team.

The event opened with remarks by MARC CEO Dr. George M. Ragheb, followed by an introduction to the alliance and the field of pharmacomicrobiomics by the project’s principal investigator, Dr. Ramy K. Aziz. Dr. Mohamed Nagy, a leading expert in pharmacogenetics and alliance member, also spoke about the importance of pharmacogenomic testing and its relevance to the emerging field of pharmacomicrobiomics.

During the workshop, Dr. Sara Zahran, the workshop coordinator, presented the project’s progress over its first six months, including the contributions of graduate and undergraduate students in updating the drug-microbiome database and identifying new drug-modifying enzyme variants. Students also presented their recent work and received expert feedback, reflecting the alliance’s strong focus on research capacity building and scientific training in Egypt.

MARC hosted the inaugural workshop of the National Pharmacomicrobiomics Alliance, a JESOR-funded project led by MARC in collaboration with Egyptian academic and research institutions. The workshop brought together leading experts and young researchers to discuss progress in pharmacomicrobiomics, highlight international collaboration with Princeton University, and support training and capacity building in this emerging field in Egypt.

large_1787649034937.jpg

medium_1787649034937.jpg

small_1787649034937.jpg

thumbnail_1787649034937.jpg

1787649034937.jpg

MARC Hosts Inaugural Workshop of the National Pharmacomicrobiomics Alliance

The forum opened with remarks from Dr. George M. Ragheb Maher, CEO of MARC, and Dr. Khaled Abu Zaid, CEO of Expert Consult, who emphasized the importance of regional collaboration and a shared patient-centered mission. Technical sessions featured leading experts discussing model-informed drug development, virtual bioequivalence, regulatory decision-making, mechanistic safe-space evaluation, ICH M15 developments, and population pharmacokinetics in bioequivalence study design.

The event concluded with an open panel discussion on the opportunities, challenges, and roadmap for adopting MIDD and virtual bioequivalence across the region. With participation from experts and regulatory representatives across several Arab countries, the forum highlighted growing momentum toward faster, safer, and more efficient drug development focused on improving patient outcomes.

MARC BE Center, in collaboration with Expert Consult Ltd., hosted the MIDD & Virtual Bioequivalence Scientific Forum on September 23, 2026, bringing together regional and international experts both in person and online to discuss the future of drug development.

Happening at MARC

22

July

Event

Regional and Global Experts Gather at MARC Forum on MIDD and Virtual Bioequivalence

22

July

Event

Regional and Global Experts Gather at MARC Forum on MIDD and Virtual Bioequivalence

02

June

PressRelease

Bioequivalence Unit receives GCC Accreditation.

28

May

PressRelease

MARC Hosts Inaugural Workshop of the National Pharmacomicrobiomics Alliance

Latest Events

PressRelease

PressRelease

Event

A newly established integrative research center that aims to advance science by conducting research into interdisciplinary disease areas

Subscribe for our latest news and updates

Follow Us

Get our latest updates and news

About MARC

MARC Solutions

Network

Newsroom

Reference Material

© 2022 MARC - All Rights Reserved